|
| Exchange Disseminated Time 01/11/2017 10:31:26 | Amrutanjan Health Care Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on November 09, 2017, inter alia, to consider and approve the
1. Un-audited Financial Results along with the Limited Review Report for the quarter and half year ended September 30, 2017.
2. Declaration of 1st interim dividend for the financial year 2017-18
In view of the above, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct to regulate, monitor and report trading by insiders, the trading window for dealing in the securities of the Company shall remain closed for the Specified Persons (Directors & Designated Employees) from November 02, 2017 to November 12, 2017 (both days inclusive). |
|
|